Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000001
Filing Date
2023-04-20
Accepted
2023-04-20 17:54:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3329
  Complete submission text file 0001974158-23-000001.txt   4885
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Subject) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40335 | Film No.: 23834112
SIC: 2834 Pharmaceutical Preparations

Mailing Address 59 5TH AVE NEW YORK NY 10003
Business Address 59 5TH AVE NEW YORK NY 10003 (914) 841-8818
A2A Pharmaceuticals, Inc. (Reporting) CIK: 0001859061 (see all company filings)

IRS No.: 813887498 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144